These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27123462)

  • 1. Calpain-Calcineurin-Nuclear Factor Signaling and the Development of Atrial Fibrillation in Patients with Valvular Heart Disease and Diabetes.
    Zhao Y; Cui GM; Zhou NN; Li C; Zhang Q; Sun H; Han B; Zou CW; Wang LJ; Li XD; Wang JC
    J Diabetes Res; 2016; 2016():4639654. PubMed ID: 27123462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Calpain-2 and calcineurin protein expression in right atrial appendages from patients underwent valve replacement with or without atrial fibrillation].
    Qing Z; Jianchun W; Yong Z; Nannan Z; Cong L; Lijuan W; Xia S
    Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Aug; 43(8):705-8. PubMed ID: 26955728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calreticulin overexpression correlates with integrin-α5 and transforming growth factor-β1 expression in the atria of patients with rheumatic valvular disease and atrial fibrillation.
    Zhao F; Zhang S; Shao Y; Wu Y; Qin J; Chen Y; Chen L; Gu H; Wang X; Huang C; Zhang W
    Int J Cardiol; 2013 Oct; 168(3):2177-85. PubMed ID: 23465222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the calcineurin-nuclear factor of activated T-cell signal transduction pathway in atrial fibrillation.
    Lin CC; Lin JL; Lin CS; Tsai MC; Su MJ; Lai LP; Huang SK
    Chest; 2004 Dec; 126(6):1926-32. PubMed ID: 15596694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of potential roles of combinatorial microRNA regulation in occurrence of valvular heart disease with atrial fibrillation based on computational evidences.
    Wang G; Rao N; Liu D; Jiang H; Liu K; Yang F; Chen Y; Huang K
    PLoS One; 2019; 14(9):e0221900. PubMed ID: 31479479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation.
    Gaborit N; Steenman M; Lamirault G; Le Meur N; Le Bouter S; Lande G; Léger J; Charpentier F; Christ T; Dobrev D; Escande D; Nattel S; Demolombe S
    Circulation; 2005 Jul; 112(4):471-81. PubMed ID: 16027256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of atrial fibrillation on microRNA expression profiles in left and right atria from patients with valvular heart disease.
    Cooley N; Cowley MJ; Lin RC; Marasco S; Wong C; Kaye DM; Dart AM; Woodcock EA
    Physiol Genomics; 2012 Feb; 44(3):211-9. PubMed ID: 22147268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profile associated with chronic atrial fibrillation and underlying valvular heart disease in man.
    Lamirault G; Gaborit N; Le Meur N; Chevalier C; Lande G; Demolombe S; Escande D; Nattel S; Léger JJ; Steenman M
    J Mol Cell Cardiol; 2006 Jan; 40(1):173-84. PubMed ID: 16242148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Rho Kinase and Its Mechanism in the Left Atrial Appendage in Patients with Atrial Fibrillation.
    Chen Y; Su F; Han J; Jiao P; Guo W
    Heart Surg Forum; 2018 Feb; 21(1):E044-E048. PubMed ID: 29485964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of cilazapril and valsartan on the mRNA and protein expressions of atrial calpains and atrial structural remodeling in atrial fibrillation dogs.
    Li Y; Li WM; Gong YT; Li BX; Liu W; Han W; Dong D; Sheng L; Xue JY; Zhang L; Chu S; Yang BF
    Basic Res Cardiol; 2007 May; 102(3):245-56. PubMed ID: 17268887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation.
    Brundel BJ; Ausma J; van Gelder IC; Van der Want JJ; van Gilst WH; Crijns HJ; Henning RH
    Cardiovasc Res; 2002 May; 54(2):380-9. PubMed ID: 12062342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Occurrence of Valvular Atrial Fibrillation: Involvement of NGF/TrKA Signaling Pathway.
    Wang Q; Zhao Y; Dong X; Li C; Zhou L; Zou C; Li X; Zhou N; Liu J; Sun Y; Wang J
    J Invest Surg; 2021 Dec; 34(12):1379-1386. PubMed ID: 32781864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proinflammatory gene expression in patients undergoing mitral valve surgery and maze ablation for atrial fibrillation.
    Tsai FC; Chang GJ; Hsu YJ; Lin YM; Lee YS; Chen WJ; Kuo CT; Yeh YH
    J Thorac Cardiovasc Surg; 2016 Jun; 151(6):1673-1682.e5. PubMed ID: 26774166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in the expression of atrial calpains in electrical and structural remodeling during aging and atrial fibrillation.
    Xu GJ; Gan TY; Tang BP; Chen ZH; Mahemuti A; Jiang T; Song JG; Guo X; Li YD; Zhou XH; Zhang Y; Li JX
    Mol Med Rep; 2013 Nov; 8(5):1343-52. PubMed ID: 24043247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Region-specific gene expression profiles in the left atria of patients with valvular atrial fibrillation.
    Yeh YH; Kuo CT; Lee YS; Lin YM; Nattel S; Tsai FC; Chen WJ
    Heart Rhythm; 2013 Mar; 10(3):383-91. PubMed ID: 23183193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II receptor type 1 is upregulated in atrial tissue of patients with rheumatic valvular disease with atrial fibrillation.
    Cong H; Li X; Ma L; Jiang H; Mao Y; Xu M
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):298-304. PubMed ID: 20080265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the microRNA signature in left atrium from patients with valvular heart disease reveals their implications in atrial fibrillation.
    Doñate Puertas R; Jalabert A; Meugnier E; Euthine V; Chevalier P; Rome S
    PLoS One; 2018; 13(5):e0196666. PubMed ID: 29723239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways.
    Liu W; Deng J; Ding W; Wang G; Shen Y; Zheng J; Zhang X; Luo Y; Lv C; Wang Y; Chen L; Yan D; Boudreau RL; Song LS; Liu J
    Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma beta-thromboglobulin and platelet factor 4 concentrations in patients with atrial fibrillation.
    Yamauchi K; Furui H; Taniguchi N; Sotobata I
    Jpn Heart J; 1986 Jul; 27(4):481-7. PubMed ID: 2946878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.